Acadia Healthcare vs PACS
ACHC and PACS side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACHC and PACS compare
PACS is the larger company, worth 2.7 times as much as Acadia Healthcare ($7.6B against $2.8B).
PACS grew revenue faster over the last twelve months (15.2% versus 4.3% for Acadia Healthcare).
PACS keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −33.4% at Acadia Healthcare.
PACS scores higher on the StockData Score (12 against 7 for Acadia Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACHC | PACS |
|---|---|---|
| Size and price | ||
| Market cap | $2.8B | $7.6B |
| Share price | $29.96 | $47.81 |
| Change, 1 year | 30.2% | 284% |
| Change, 5 years | −53.3% | – |
| Beta (5Y) | 0.65 | 0.03 |
| Employees | 25K | 47K |
| StockData Score | ||
| Total score | 7 | 12 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 2 | 4 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 27.3× |
| P/S | 0.8× (better) | 1.4× |
| P/B | 1.4× (better) | 6.8× |
| EV/EBITDA | – | 18.7× |
| PEG | – | 19.45 |
| FCF yield | −4.8% | – |
| Fair value | $67.36 | $39.82 |
| Margin of safety | 55.5% (better) | −20.1% |
| Growth | ||
| Revenue growth (TTM) | 4.3% | 15.2% (better) |
| Revenue growth, 5Y average | 9.7% | – |
| Net income growth (TTM) | −909% | 104% (better) |
| EPS growth (TTM) | −938% | 113% (better) |
| Profitability | ||
| Gross margin | – | 23.5% |
| Operating margin | – | 7.4% |
| Net margin | −33.4% | 4.8% (better) |
| FCF margin | −4.0% | – |
| Return on equity | −44.5% | 28.1% (better) |
| Return on invested capital | – | 29.4% |
| Financial health | ||
| Debt / equity | 1.22 | 0.22 (better) |
| Net debt / EBITDA | – | 0.20 |
| Interest coverage | – | 13.9× |
| Current ratio | 1.57 (better) | 0.91 |
| Altman Z-score | 0.98 | 2.32 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 145% | 31.3% |
| Held by insiders | 1.9% | 78.7% |
| Insider net buying, 12 months | – | −$79.4M |
| Short interest, % of float | 24.9% | 12.2% |
Go deeper
- ACHC stock overview
- ACHC income statement
- ACHC valuation and score
- PACS stock overview
- PACS income statement
- PACS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.